Effect of the essential oil of Chrysactinia mexicana A. Gray on clinical isolates of Candida glabrata

The objective of this work was to evaluate the effect of the Chrysactinia mexicana A. Gray essential oil, on C. glabrata clinical isolates. The essential oil was obtained by steam entrainment of flowers, leaves and secondary branches of C. mexicana. Gas chromatography and mass spectrometry were perf...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gallegos-García, Verónica, Medina-de la Cruz, Omar, Leal-Morales, Carlos Alberto, Meza-Menchaca, Thuluz, Guillen, Larissa, Juárez-Flores, Bertha Irene
Formato: Online
Lenguaje:spa
Publicado: Universidad de Sonora 2021
Acceso en línea:https://biotecnia.unison.mx/index.php/biotecnia/article/view/1265
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
Descripción
Sumario:The objective of this work was to evaluate the effect of the Chrysactinia mexicana A. Gray essential oil, on C. glabrata clinical isolates. The essential oil was obtained by steam entrainment of flowers, leaves and secondary branches of C. mexicana. Gas chromatography and mass spectrometry were performed to determine the oil composition. Logarithmic and stationary phase microdilution assays were performed with Saccharomyces cerevisiae and clinical isolates of C. gla­brata to determine the Minimum Inhibitory Concentration (MIC) of the oil. The cultures were incubated in liquid YPD medium, for 7 h in fresh medium (logarithmic phase) or 3 h in recovering medium (stationary phase), with the oil and microdilution tests were performed. The three main oil compounds identified were piperitone (29.57%), eucalyptol (26.86%) and α-terpineol (14.65%). The MICs obtained were, a) stationary phase: S. cerevisiae (BY4741) 2.78 mg/mL and C. glabrata (CBS138), (NY66) and (AN400) 6.50 mg/mL and (NY62) 9.29 mg/mL; b) logarithmic phase: S. cerevisiae (BY4741) 3.71 mg/mL and C. glabrata (CBS138) 4.64 mg/mL, (NY66) 6.5 mg/mL, (AN400) 8.36 mg/mL, and (NY62) 18.5 mg/ mL. This work constitutes the first report of the fungicidal effect of the C. mexicana essential oil on human pathogenic fungi such as C. glabrata.